MedTrace Logo

Coronavirus Pediatric Serological Study

NCT05128435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2021-11-22

No results posted yet for this study

Summary

The Coronavirus Pediatric Serological Study's aim is to provide a better insight of children's immune response after SARS-CoV-2 infection.

Serological tests were conducted on blood samples taken 3 to 5 months after the children's viral infection.

The study was performed in collaboration with the Institute of Medical Immunology, were antibody levels were measured and immunoglobulin subclasses profiles were studied.

Conditions

  • SARS-CoV2 Infection

Interventions

DIAGNOSTIC_TEST

Blood sample

Blood sample taken 3 to 5 months after the infection

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Saint Pierre

    lead OTHER

Eligibility

Min Age
0 Months
Max Age
179 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-12-31
Completion
2021-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05128435 on ClinicalTrials.gov